Outcome

Hyperbaric oxygen therapy (HBOT) at 2.4 atm significantly influences gene expression in human microvascular endothelial cells affecting over 8100 genes. Key up-regulated genes include transcription factors FOS FOSB JUNB and metallothioneins with the Nrf-2 oxidative stress response pathway being crucial.

Introduction

Hyperbaric oxygen therapy (HBOT) has been identified as a potent enhancer of cellular adaptation and repair through significant gene regulation. In a recent study on human microvascular endothelial cells (HMEC-1) a single 60-minute HBOT session at 2.4 atmospheres absolute (atm) markedly regulated over 8100 genes. Key up-regulated genes included immediate early transcription factors such as FOS FOSB and JUNB as well as metallothioneins. The Nrf-2 oxidative stress response pathway emerged as a critical regulator in this process. HBOT protected endothelial cells against oxidative stress enhanced cell proliferation and promoted the formation of endothelial tubes on Matrigel plates especially after multiple treatments. These findings underline the potential of HBOT to improve wound healing and to prepare patients for surgery by fostering endothelial protection and repair suggesting broader applications for HBOT in medical protocols aimed at enhancing endothelial health and function.

Results

The research conducted on human microvascular endothelial cells (HMEC-1) has demonstrated that a single 60-minute session of hyperbaric oxygen treatment (HBOT) at 2.4 atmospheres absolute (atm) effects substantial genetic regulation. Specifically the study identified that HBOT significantly altered the expression of over 8100 genes both immediately after treatment and following a 24-hour recovery period. Notably key up-regulated genes included immediate early transcription factors such as FOS FOSB JUNB metallothioneins and 20 molecular chaperones which are pivotal in mitigating protein damage.

One of the most critical pathways affected by HBOT was the Nrf-2 oxidative stress response pathway essential for cellular defense against oxidative damage. The study highlighted that HBOT unlike 100% oxygen at 1 atm considerably enhanced cell proliferation and promoted endothelial tube formation on Matrigel plates. These effects were further accentuated after two daily HBOT sessions.

Additionally HBOT demonstrated a protective role for endothelial cells under oxidative stress. Enhanced cell proliferation and tube formation which are critical steps in angiogenesis and wound healing were more pronounced with multiple treatments. These findings underscore the significant therapeutic potential of HBOT in enhancing endothelial cell function and repair mechanisms.

The results suggest that HBOT can be effectively utilized to improve wound-healing protocols and precondition patients for surgery by fostering endothelial protection and repair. By promoting increased expression of immediate early and cytoprotective genes HBOT enhances oxidative stress resistance offering a robust therapeutic strategy for endothelial health.

Overall the study provides comprehensive insights into the molecular changes induced by HBOT outlining its profound impact on endothelial cell protection proliferation and angiogenesis. This understanding facilitates the potential optimization of HBOT in clinical settings paving the way for innovative therapeutic approaches for cardiovascular and blood conditions.

Conclusion

In conclusion this study underscores the profound impact of hyperbaric oxygen therapy (HBOT) at 2.4 atm on human microvascular endothelial cells (HMEC-1) marked by the regulation of over 8100 genes. The up-regulation of key transcription factors such as FOS FOSB and JUNB alongside the activation of the Nrf-2 oxidative stress response pathway illustrates HBOT’s capacity to enhance oxidative stress resistance and stimulate cell proliferation. Furthermore the enhanced endothelial tube formation observed after multiple treatments signifies HBOT’s potential in promoting angiogenesis and facilitating wound healing. These findings highlight HBOT as a promising therapeutic intervention for endothelial protection and repair with significant implications for developing wound healing protocols and preconditioning patients for surgery. Future research should focus on refining HBOT protocols to maximize these benefits and exploring its broader applications in cardiovascular health and regenerative medicine.